TOBAM’s Exelixis EXEL Stock Holding History

TOBAM’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,821	Closed	-$167K	–	441
2020 Q3	$167K	Buy	+6,821	New	+$159K	0.01%	181
2019 Q2	–	Sell	-4,508	Closed	-$107K	–	129
2019 Q1	$107K	Sell	4,508 -4,322	-49%	-$98.6K	0.01%	125
2018 Q4	$174K	Buy	+8,830	New	+$157K	0.01%	135

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

TOBAM's EXEL Position: Q4 2020 in Review

TOBAM sold out of Exelixis (EXEL) in Q4 2020, closing a stake of 6,821 shares — an estimated $167K sold.

TOBAM first reported a position in EXEL in Q4 2018 and held it in 3 quarters. The position peaked at $174K in Q4 2018. 351 funds tracked by Wall St. Rank hold EXEL as of Q4 2020.

TOBAM reported no remaining Exelixis position as of Q4 2020 after selling out during the quarter.
TOBAM sold 6,821 Exelixis shares in Q4 2020, an estimated $167K.
TOBAM first reported a position in Exelixis in Q4 2018 and held it in 3 quarters.
TOBAM's Exelixis position peaked at $174K in Q4 2018.
351 funds tracked by Wall St. Rank held Exelixis as of Q4 2020.

Based on TOBAM's 13F filing for Q4 2020, filed 3 Feb 2021.